Enzolytics Inc (ENZC)

[falon]

Spring is in the AIR and I smell the SCENT of a PRESS RELEASE in the not so distant future.

What will it be?

ENZC news will be released when CHARLES who is Charge has something to report to the shareholders. He has done so in the past and will continue to do so in the future. There is a variety of activities presently going on with ENZC that we know about and many that we don’t.

There have been 19 Press Releases since September 2020 which is about 2 per month. Don’t expect 2 press releases per month but do expect press releases to come when Charles has something to report.

Activities awaiting updates of what we know about:

1. NSF and NIH applications Forthcoming

2. Additional Funding Anytime

3. Texas A&M University Institute for Preclinical Studies. Anytime

4. PCAOB Audit April 2021

5. Toxicity Study Anytime

6. Progress on ENZC plans to further develop additional anti-HIV monoclonal antibodies and to now begin the production of fully human monoclonal antibodies targeting the CoronaVirus Anytime

7. Status on the completion of production of monoclonal antibodies against both the HIV virus and the CoronaVirus Anytime

8. Status of testing in combination the Enzolytics ITV-1 peptide in conjunction with our anti-HIV monoclonal antibodies. There is reason to believe that there will be synergistic effect achieved with this combination therapy. Anytime

9. Status on the process of identifying a clinical research organization for the preparation of pre-IND protocols for submission to the FDA. Anytime

10. GMP manufacturer Anytime

11. Status of finalizing the necessary steps for completing the permitting process for our ITV-1 HIV/AIDS therapeutic in Bulgaria.
Anytime

12. Status of received proposals from FDA approved manufacturers to produce the quantities necessary for such certification. Under Review

13. Results of testing of the newly produced monoclonal antibodies. This includes testing of our now being produced recombinant anti-HIV monoclonal antibodies created from the parent antibody. Such testing is now scheduled for early 2021 at the University of Strasbourg in Strasbourg, France. Additional testing of the Company's antibodies is also being planned at San Raffaele Scientific Institute, Milan, Italy.
Early 2021

14. Acquisition Anytime

15. Status of collaborative opportunities with other drug development companies to expand our product reach. Forthcoming

16. GileadRelationship

17. Eli LilyRelationship

18. Immunome Relationship

There will be other updates of activities we don’t know about however based on the processes of Biotechnologies companies one can surmise what these could possibly be. Anytime


Remember two things.

First and foremost CHARLES is in Charge

Second and very important from the Press Release dated October 19, 2020:

All of our steps are taken with two objectives in mind. First our focus is on creating successful therapeutics against infectious diseases, including HIV and now our focus on the Coronavirus. Secondly, our efforts are also intended to increase the value of our technology and the value of our company - which directly translates into value for our investors. Please know that these are our two guiding objectives with every effort we make.

The link below has all ENZC Press Releases:

https://marketwirenews.com/stock/enzc/news/